Eagle Health Investments LP

Position in RARE — Ultragenyx Pharmaceutical Inc.

CIK 1842545 Greenwich, CT

Position in RARE

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$29,520,800

+$10,998,466 QoQ

Shares Held

884,121

0.0% QoQ

Ownership

0.897%

of shares outstanding

% of Portfolio

4.89%

of 13F equity value

Holder Rank

#27

of 310 holders

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Eagle Health Investments LP holds $387,533,407 across 16 Biotechnology names. RARE ranks #6 (7.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	76,417	$70,897,400
2	INSM	INSMED Inc	384,130	$40,955,940
3	BMRN	Biomarin Pharmaceutical Inc	624,676	$35,743,960
4	SRRK	Scholar Rock Holding Corp	555,272	$30,539,960
5	PTGX	Protagonist Therapeutics, Inc	248,322	$30,439,310
6	RARE	Ultragenyx Pharmaceutical Inc. This page	884,121	$29,520,800
7	ASND	Ascendis Pharma A/S	106,158	$28,314,461
8	RVMD	Revolution Medicines, Inc.	120,346	$22,538,398

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$29,520,800	884,121	0.0%	Shares	Sole	2026-08-10
2026-03-31	$18,522,334	884,121	+26.8%	Shares	Sole	2026-05-15
2025-09-30	$20,965,760	697,000	+11.1%	Shares	Sole	2025-11-07
2025-06-30	$22,819,536	627,600	0.0%	Shares	Sole	2025-08-12
2025-03-31	$22,725,396	627,600	0.0%	Shares	Sole	2025-05-12
2024-12-31	$26,403,132	627,600	+11.7%	Shares	Sole	2025-02-12
2024-09-30	$31,202,435	561,700	+7.1%	Shares	Sole	2024-11-12
2024-06-30	$21,556,950	524,500	+75.0%	Shares	Sole	2024-08-13
2024-03-31	$13,992,993	299,700	—	Shares	Sole	2024-05-14
No filing history on record for this holder in this stock.